Aprogen Medicines Market Cap

Aprogen Medicines has a market cap or net worth of 93.8 billion as of April 2, 2026. Its market cap has decreased by -56.92% in one year.

Market Cap

93.80B

Enterprise Value

531.20B

Revenue

117.97B

Ranking

n/a

PE Ratio

n/a

Stock Price

304.00

Market Cap Chart

Since December 7, 1995, Aprogen Medicines's market cap has increased from 19.56B to 93.80B, an increase of 379.54%. That is a compound annual growth rate of 5.30%.

Market Cap History

Date	Market Cap	% Change
Apr 3, 2026	93.80B	-56.38%
Dec 30, 2025	215.06B	-2.20%
Dec 30, 2024	219.89B	-6.16%
Dec 28, 2023	234.32B	-41.38%
Dec 27, 2022	399.71B	19.11%
Dec 30, 2021	335.57B	-10.30%
Dec 30, 2020	Upgrade Pro	Upgrade Pro
Dec 30, 2019	Upgrade Pro	Upgrade Pro
Dec 28, 2018	Upgrade Pro	Upgrade Pro
Dec 28, 2017	Upgrade Pro	Upgrade Pro
Dec 29, 2016	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Samyang Holdings	457.62B
KG Chemical	348.27B
KPX Holdings	312.75B
Woongjin	212.16B
HS HYOSUNG	198.28B
JLK, Inc.	172.62B
Gridwiz	169.97B
HLB GLOBAL	103.09B

Market Cap Rankings